Posts by cstephenson@legacymedsearch.com
Candela Introduces the New FDA-Cleared Profound Matrix™ System
Candela, the leading provider of energy-based solutions worldwide, and the pioneer of the first and only long-pulse radiofrequency (RF) microneedling device, announces the launch of the all-new Profound Matrix™ system. Designed to correct, maintain, and restore skin at various stages of the aging journey, this multi-application system features the Sublime™, Sublative™ RF, and all-new Matrix…
Read MoreVERO Biotech’s Second Generation GENOSYL® Delivery System (DS) Receives FDA Approval in Anesthesia in the Surgical Suite
VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, announced FDA approval of its innovative second generation GENOSYL® Inhaled Nitric Oxide (iNO) delivery system for use with rebreathing anesthesia in the operating room setting. Second generation GENOSYL®DS is now the first and only device for iNO…
Read MoreRefleXion Receives FDA Clearance for SCINTIX Biology-Guided Radiotherapy; Cutting-edge Treatment Applicable for Early and Late-stage Cancers
RefleXion Medical, a therapeutic oncology company, announced the U.S. Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX™ biology-guided radiotherapy, a cutting-edge treatment applicable for early and late-stage cancers. The company will host a live-stream event featuring both its co-founder and CEO discussing the breakthrough significance of SCINTIX therapy for cancer…
Read MoreTyber Medical LLC Acquires ADSM-Synchro Medical
Tyber Medical LLC has acquired 100 percent of the capital of ADSM-Synchro Medical, a French orthopedic medical device company, specializing in the development and distribution of implants dedicated to treating surgical forefoot pathologies. Founded in 2010, ADSM has become a market leader in the European medical device industry with products like the ToeGrip Classic, the…
Read MoreAxonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced that the U.S. Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation system. The newly approved Axonics R20™ neurostimulator is labeled for a functional life in the body of at…
Read MoreAble Medical Announces Launch of Valkyrie® Looped Sternotomy Sutures
Able Medical Devices announced the launch of Valkyrie® Looped Sternotomy Sutures. The stainless-steel looped wire sutures are used to close a patient’s chest after open heart surgery. When compared to traditional wire sutures, the Valkyrie Looped Suture doubles the surface area of single wires and provides a more robust sternal closure. Valkyrie Looped Sternotomy Sutures…
Read MoreThe Legacy MEDSearch Layoff Survival Guide
As the economy slows, layoffs, unfortunately, become more common. It’s never easy to be laid off, but our team has a couple of tips to share to help you recover quickly and find a new role that is right for you. It can be hard to stay calm in an overwhelming and unexpected situation,…
Read MoreConventus Flower Orthopedics Announces Expansion of its Flex-Thread™ Technology Platform with FDA Clearance of the Ulna Intramedullary Nail System
Conventus Flower Orthopedics, an innovation-driven medical technology company, announced they have received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Flex-Thread™ Ulna Intramedullary (IM) Nail System. The Flex-Thread Ulna Nail marks a new application and portfolio expansion to the company’s Flex-Thread technology platform. Expected to launch in February 2023, the Flex-Thread Ulna IM Nail…
Read MoreFDA Clears Cytovale’s® IntelliSep® Sepsis Test, First in a New Class of Emergency Department-Focused Diagnostic Tools
Cytovale®, a medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, announced today that its IntelliSep® test has received U.S. Food and Drug Administration (FDA) 510(k) clearance to aid in the early detection of sepsis for the approximately 30 million adult patients with signs and symptoms of infection who present…
Read MoreHip Innovation Technology Announces Initiation of FDA Approved Investigational Device Exemption Study
Hip Innovation Technology, LLC (HIT), a medical device company developing innovative orthopaedic device solutions to advance the quality of life and quality of care for patients, is pleased to announce the first U.S. implantation of the HIT Reverse Hip Replacement System (Reverse HRS), under an FDA approved Investigational Device Exemption (IDE). The IDE Study is…
Read More